ENSG00000196218


Homo sapiens

Features
Gene ID: ENSG00000196218
  
Biological name :RYR1
  
Synonyms : P21817 / ryanodine receptor 1 / RYR1
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 19
Strand: 1
Band: q13.2
Gene start: 38433699
Gene end: 38587564
  
Corresponding Affymetrix probe sets: 205485_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000472497
Ensembl peptide - ENSP00000471601
Ensembl peptide - ENSP00000472126
Ensembl peptide - ENSP00000347667
Ensembl peptide - ENSP00000352608
Ensembl peptide - ENSP00000470848
Ensembl peptide - ENSP00000470927
Ensembl peptide - ENSP00000471404
NCBI entrez gene - 6261     See in Manteia.
OMIM - 180901
RefSeq - XM_011527205
RefSeq - NM_000540
RefSeq - NM_001042723
RefSeq - XM_006723317
RefSeq - XM_006723319
RefSeq Peptide - NP_000531
RefSeq Peptide - NP_001036188
swissprot - M0QZY3
swissprot - M0R014
swissprot - M0R0S0
swissprot - M0R127
swissprot - M0R2E2
swissprot - M0R1U6
swissprot - P21817
Ensembl - ENSG00000196218
  
Related genetic diseases (OMIM): 117000 - Central core disease, 117000
  145600 - King-Denborough syndrome, 145600
  255320 - Minicore myopathy with external ophthalmoplegia, 255320
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 ryr1aENSDARG00000011422Danio rerio
 ryr1bENSDARG00000023797Danio rerio
 Ryr1ENSMUSG00000030592Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
RYR3 / Q15413 / ryanodine receptor 3ENSG0000019883865
RYR2 / Q92736 / ryanodine receptor 2ENSG0000019862665
ITPR1 / Q14643 / inositol 1,4,5-trisphosphate receptor type 1ENSG0000015099513
ITPR3 / Q14573 / inositol 1,4,5-trisphosphate receptor type 3ENSG0000009643313
ITPR2 / Q14571 / inositol 1,4,5-trisphosphate receptor type 2ENSG0000012310413


Protein motifs (from Interpro)
Interpro ID Name
 IPR000699  RIH domain
 IPR001870  B30.2/SPRY domain
 IPR002048  EF-hand domain
 IPR003032  Ryanodine receptor Ryr
 IPR003877  SPRY domain
 IPR005821  Ion transport domain
 IPR009460  Ryanodine Receptor TM 4-6
 IPR011992  EF-hand domain pair
 IPR013320  Concanavalin A-like lectin/glucanase domain superfamily
 IPR013333  Ryanodine receptor
 IPR013662  RyR/IP3R Homology associated domain
 IPR014821  Inositol 1,4,5-trisphosphate/ryanodine receptor
 IPR015925  Ryanodine receptor-related
 IPR016093  MIR motif
 IPR033215  Ryanodine receptor 1
 IPR035761  Ryanodine receptor, SPRY domain 1
 IPR035762  Ryanodine receptor, SPRY domain 3
 IPR035764  Ryanodine receptor, SPRY domain 2
 IPR035910  RyR/IP3 receptor binding core, RIH domain superfamily
 IPR036300  Mir domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0001666 response to hypoxia IDA
 biological_processGO:0003151 outflow tract morphogenesis IEA
 biological_processGO:0006811 ion transport IEA
 biological_processGO:0006816 calcium ion transport IEA
 biological_processGO:0006874 cellular calcium ion homeostasis IEA
 biological_processGO:0006936 muscle contraction IEA
 biological_processGO:0007275 multicellular organism development IEA
 biological_processGO:0014808 release of sequestered calcium ion into cytosol by sarcoplasmic reticulum IEA
 biological_processGO:0031000 response to caffeine ISS
 biological_processGO:0034220 ion transmembrane transport TAS
 biological_processGO:0043588 skin development IEA
 biological_processGO:0043931 ossification involved in bone maturation IEA
 biological_processGO:0048741 skeletal muscle fiber development IEA
 biological_processGO:0051209 release of sequestered calcium ion into cytosol IEA
 biological_processGO:0051289 protein homotetramerization ISS
 biological_processGO:0051480 regulation of cytosolic calcium ion concentration ISS
 biological_processGO:0055085 transmembrane transport IEA
 biological_processGO:0070588 calcium ion transmembrane transport IEA
 biological_processGO:0071277 cellular response to calcium ion ISS
 biological_processGO:0071313 cellular response to caffeine IEA
 biological_processGO:1903779 regulation of cardiac conduction TAS
 cellular_componentGO:0005623 cell IEA
 cellular_componentGO:0005737 cytoplasm IDA
 cellular_componentGO:0005790 smooth endoplasmic reticulum TAS
 cellular_componentGO:0005886 plasma membrane IDA
 cellular_componentGO:0005887 integral component of plasma membrane TAS
 cellular_componentGO:0005938 cell cortex IDA
 cellular_componentGO:0014701 junctional sarcoplasmic reticulum membrane TAS
 cellular_componentGO:0014802 terminal cisterna ISS
 cellular_componentGO:0016020 membrane IEA
 cellular_componentGO:0016021 integral component of membrane IEA
 cellular_componentGO:0016529 sarcoplasmic reticulum ISS
 cellular_componentGO:0030314 junctional membrane complex IEA
 cellular_componentGO:0030315 T-tubule IEA
 cellular_componentGO:0031301 integral component of organelle membrane ISS
 cellular_componentGO:0031674 I band IDA
 cellular_componentGO:0032991 protein-containing complex IEA
 cellular_componentGO:0033017 sarcoplasmic reticulum membrane TAS
 cellular_componentGO:0070062 extracellular exosome HDA
 cellular_componentGO:1990425 ryanodine receptor complex ISS
 molecular_functionGO:0000166 nucleotide binding IEA
 molecular_functionGO:0002020 protease binding IEA
 molecular_functionGO:0005216 ion channel activity IEA
 molecular_functionGO:0005219 ryanodine-sensitive calcium-release channel activity IEA
 molecular_functionGO:0005245 voltage-gated calcium channel activity IEA
 molecular_functionGO:0005262 calcium channel activity IEA
 molecular_functionGO:0005509 calcium ion binding IBA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0005516 calmodulin binding ISS
 molecular_functionGO:0005524 ATP binding ISS
 molecular_functionGO:0015278 calcium-release channel activity IEA
 molecular_functionGO:0019899 enzyme binding IEA
 molecular_functionGO:0046872 metal ion binding IEA
 molecular_functionGO:0048763 calcium-induced calcium release activity IMP


Pathways (from Reactome)
Pathway description
Stimuli-sensing channels
Ion homeostasis


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000006 Autosomal dominant inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in heterozygotes. In the context of medical genetics, an autosomal dominant disorder is caused when a single copy of the mutant allele is present. Males and females are affected equally, and can both transmit the disorder with a risk of 50% for each child of inheriting the mutant allele." [HPO:curators]
Show

 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000218 High palate "Height of the palate more than 2 SD above the mean (objective) or palatal height at the level of the first permanent molar more than twice the height of the teeth (subjective)." [pmid:19125428]
Show

 HP:0000275 Narrow face 
Show

 HP:0000276 Long face 
Show

 HP:0000508 Ptosis "Drooping of the eyelid." [HPO:curators]
Show

 HP:0000544 External ophthalmoplegia 
Show

 HP:0000602 Ophthalmoplegia 
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001270 Motor retardation 
Show

 HP:0001283 Bulbar palsy "Bulbar weakness (or bulbar palsy) refers to bilateral impairment of function of the lower cranial nerves IX, X, XI and XII, which occurs due to lower motor neuron lesion either at nuclear or fascicular level in the medulla or from bilateral lesions of the lower cranial nerves outside the brain-stem. Bulbar weakness is often associated with difficulty in chewing, weakness of the facial muscles, dysarthria, palatal weakness and regurgitation of fluids, dysphagia, and dysphonia." [HPO:curators]
Show

 HP:0001284 Areflexia 
Show

 HP:0001319 Neonatal hypotonia "Muscular hypotonia (abnormally low muscle tone) manifesting in the neonatal period." [HPO:curators]
Show

 HP:0001371 Contractures 
Show

 HP:0001374 Congenital hip dislocation 
Show

 HP:0001388 Joint laxity 
Show

 HP:0001425 Heterogeneous 
Show

 HP:0001508 Failure to thrive 
Show

 HP:0001558 Decreased fetal movement "An abnormal reduction in quantity or strength of fetal movements." [HPO:curators]
Show

 HP:0001561 Polyhydramnios 
Show

 HP:0001612 Weak cry 
Show

 HP:0001644 Dilated cardiomyopathy 
Show

 HP:0001649 Tachycardia "A rapid heartrate that exceeds the range of the normal resting heartrate for age." [HPO:curators]
Show

 HP:0001763 Pes planus "A condition in which the arch of the foot is flat, with the entire sole of the foot being in near-complete contact with the ground." [HPO:curators]
Show

 HP:0001789 Hydrops fetalis 
Show

 HP:0001945 Fever 
Show

 HP:0002015 Dysphagia "Difficulty in swallowing." [HPO:curators]
Show

 HP:0002047 Malignant hyperthermia "Malignant hyperthermia is characterized by a rapid increase in temperature to 39-42 degrees C in response to inhalational anesthetics such as halothane or to muscle relaxants such as succinylcholine." [HPO:curators]
Show

 HP:0002058 Myopathic facies "A facial appearance characteristic of myopathic conditions. The face appears expressionless with sunken cheeks, bilateral ptosis, and inability to elevate the corners of the mouth, due to muscle weakness." [HPO:curators]
Show

 HP:0002063 Rigidity 
Show

 HP:0002089 Pulmonary hypoplasia 
Show

 HP:0002093 Respiratory insufficiency 
Show

 HP:0002153 Hyperkalemia 
Show

 HP:0002205 Recurrent respiratory infections 
Show

 HP:0002615 Hypotension 
Show

 HP:0002650 Scoliosis "The presence of an abnormal lateral curvature of the spine." [HPO:curators]
Show

 HP:0002747 Respiratory insufficiency due to muscle weakness 
Show

 HP:0002751 Kyphoscoliosis 
Show

 HP:0002905 Hyperphosphatemia 
Show

 HP:0002913 Myoglobinuria 
Show

 HP:0002938 Lumbar hyperlordosis 
Show

 HP:0003121 Limb contractures 
Show

 HP:0003198 Myopathy 
Show

 HP:0003201 Rhabdomyolysis 
Show

 HP:0003202 Amyotrophy "The presence of muscular atrophy (which is also known as amyotrophy)." [HPO:curators]
Show

 HP:0003236 Elevated serum creatine phosphokinase 
Show

 HP:0003256 Abnormalities of the clotting factors 
Show

 HP:0003324 Generalized muscle weakness "Generalized weakness or decreased strength of the muscles." [HPO:curators]
Show

 HP:0003327 Axial muscle weakness "Reduced strength of the axial musculature (i.e., of the muscles of the head and neck, spine, and ribs)." [HPO:curators]
Show

 HP:0003557 Increased variability in muscle fiber size "An abnormally high degree of muscle fiber size variation. This phenotypic feature can be observed upon muscle biopsy." [HPO:curators]
Show

 HP:0003560 Muscular dystrophy "The term dystrophy means abnormal growth. However, muscular dystrophy is used to describe primary myopathies with a genetic basis and a progressive course characterized by progressive skeletal muscle weakness, defects in muscle proteins, and the apoptosis of muscle cells." [HPO:curators]
Show

 HP:0003577 Onset at birth 
Show

 HP:0003593 Early onset 
Show

 HP:0003623 Onset in neonatal period 
Show

 HP:0003677 Slow progression 
Show

 HP:0003680 Nonprogressive disorder 
Show

 HP:0003687 Centralized nuclei 
Show

 HP:0003701 Proximal muscle weakness "A lack of strength of the proximal muscles." [HPO:curators]
Show

 HP:0003738 Exercise-induced myalgia "The occurrence of an unusually high amount of muscle pain following exercise." [HPO:curators]
Show

 HP:0003755 Type 1 fibers are at least 12% smaller than type 2 fibers "The presence of abnormal muscle fiber size such that type 1 fibers are at least 12% smaller than type 2 fibers (in general, this feature can only be observed on muscle biopsy)." [HPO:curators]
Show

 HP:0003787 Type 1 and type 2 muscle fibers with minicore regions of sarcomeric disorganization, lack of oxidative activity, and absent mitochondria 
Show

 HP:0003798 Nemaline bodies "Nemaline rods are abnormal bodies are abnormal that can occur in skeletal muscle fibers. THe rods can be observed on histological analysis of muscle biopsy tissue or upon electron microscopy, where they appear either as extensions of sarcomeric Z-lines, in random array without obvious attachment to Z-lines (often in areas devoid of sarcomeres) or in large clusters localized at the sarcolemma or intermyofibrillar spaces." [HPO:curators, pmid:11333380]
Show

 HP:0003803 Type 1 muscle fiber predominance "An abnormal predominance of type I muscle fibers (in general, this feature can only be observed on muscle biopsy)." [HPO:curators]
Show

 HP:0003812 Phenotypic variability 
Show

 HP:0003828 Variable expressivity 
Show

 HP:0005967 Mixed respiratory and metabolic acidosis 
Show

 HP:0008872 Feeding problems in infancy 
Show

 HP:0009025 Increased connective tissue "The presence of an abnormally increased amount of connective tissue." [HPO:curators]
Show

 HP:0009046 Difficulty walking, running, climbing stairs 
Show

 HP:0010628 Facial muscle weakness "A weakness of any or all of the muscles of the face of any etiology." [HPO:curators]
Show

 HP:0011968 Feeding difficulties "Impaired ability to eat related to problems gathering food and getting ready to suck, chew, or swallow it." [ISCA:eriggs]
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000196218 RYR1 / P21817 / ryanodine receptor 1  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr